Document ID: chunk:federal_register_of_legislation:F2024L01037:clause:4_24
Version: federal_register_of_legislation:F2024L01037
Segment Type: clause
Provision Reference: sch 4 cl 24
Character Range: 15781–17277

24  Information to be included on the label
 (1) The label of a psilocybine product, other than a psilocybine product that is extemporaneously compounded by a pharmacist for a particular patient, must contain all of the following information:
           (a) the name of the psilocybine product;
           (b) the name of the active ingredient;
           (c) the quantity of the active ingredient in mg;
           (d) the dosage form;
           (e) the quantity of the psilocybine product;
           (f) the batch number, preceded by the batch number prefix;
           (g) the expiry date, preceded by the expiry date prefix;
           (h) the name of the sponsor;
           (i) the contact details of the sponsor;
           (j) the storage conditions applicable to the psilocybine product;
           (k) for a psilocybine extract product—all of the following:
 (i) the quantity of psilocybine in mg;
 (ii) the quantity of psilocin in mg;
 (iii) the quantity of each nominated tryptamine in mg (if any);
 (iv) the quantity of the psilocybine extract and the minimum dry weight or fresh weight of the plant material from which it was prepared, including the word "minimum";
 (v) the words "Psilocybe cubensis";
 (vi) the plant part;
 (vii) the preparation type.
 (2) All of the information that is required to be included on the label of a psilocybine product must be:
           (a) in English; and
           (b) legible, clearly visible and not obscured; and
           (c) durable.